Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers Article

Vicus, Danielle, Rosen, Barry, Lubinski, Jan et al. (2009). Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers . GYNECOLOGIC ONCOLOGY, 115(1), 135-137. 10.1016/j.ygyno.2009.06.012

Open Access International Collaboration

cited authors

  • Vicus, Danielle; Rosen, Barry; Lubinski, Jan; Domchek, Susan; Kauff, Noah D; Lynch, Henry T; Isaacs, Claudine; Tung, Nadine; Sun, Ping; Narod, Steven A

sustainable development goals

authors

publication date

  • October 1, 2009

published in

keywords

  • BRCA1 mutation
  • CARCINOMA
  • CONTRALATERAL BREAST-CANCER
  • ENDOMETRIAL CANCER
  • Life Sciences & Biomedicine
  • Obstetrics & Gynecology
  • Oncology
  • Ovarian cancer
  • SURGICAL ADJUVANT BREAST
  • Science & Technology
  • THERAPY
  • Tamoxifen
  • WOMEN

Digital Object Identifier (DOI)

publisher

  • ACADEMIC PRESS INC ELSEVIER SCIENCE

start page

  • 135

end page

  • 137

volume

  • 115

issue

  • 1